Astudy published in the journal Psychological Science found that young adults—contrary to how they are sometimes portrayed in the media—tend to make highly rational decisions when it comes to selecting potential romantic partners.
This is not to say that young adults make risk-free choices, but they appear to consider both the risks and benefits of their sexual behavior in a highly consistent and thoughtful manner.
“There is a tendency to view sexual decision making in young adults as a highly variable and somewhat random process, more influenced by hormones or impulsivity than rational processes,” said Laura Hatz, a doctoral candidate at the University of Missouri and lead author of the study. “Our study suggests, however, that young adults are highly consistent in their choices, balancing potential partners’ level of attractiveness against the potential risk for sexually transmitted infection.”
The research involved presenting 257 participants with hypothetical “sexual gambles” in which a photo of a potential partner’s face was shown alongside an associated, though purely hypothetical, risk of contracting a sexually transmitted infection. Nearly all participants in the study made consistently rational choices, as defined by established models of psychological behavior. Prior research has shown that, in general, individuals tend to use what are known as heuristic decision strategies—cognitive shortcuts that may ignore some information—to make choices in life.
Hatz and her colleagues found that even individuals who could be identified as classic heuristic decision makers for monetary-based choices became rational decision makers when similar choices were framed as sexual choices.
Relationship factors affect decisions about contraceptive use among young adults
Laura E. Hatz et al, Young Adults Make Rational Sexual Decisions, Psychological Science (2020). DOI: 10.1177/0956797620925036
Safe sex or risky romance? Young adults make the rational choice (2020, October 16)
retrieved 17 October 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022